Press releases

The medac group is strengthening its international brand identity. As of 1 April 2026, the company’s production sites in Brno and Dessau operate under the shared name medac pharma production.

Today medac, a globally active pharmaceutical company specialising in therapeutic solutions for oncology, rheumatology, urology and hematology, announced the acquisition of Biotech Pharma, based in Dubai.

medac and Clinigen, a global specialty pharmaceutical services Group, are expanding their existing cooperation. Six key drugs produced by medac in the fields of oncology, haematology and immune-mediated diseases will be exclusively licensed and distributed by Clinigen in Australia, parts of Southeast Asia and China (APAC)

During a satellite symposium organised by medac at the annual congress of the European Alliance of Associations for Rheumatology (EULAR) 2025 in Barcelona, experts presented new real-world findings on methotrexate (MTX) in combination therapy for patients with rheumatoid arthritis (RA).

With the support of an independent educational grant from medac, Medscape has released an on-demand recording of the symposium “Optimizing Conditioning Regimens for HSCT in AML/MDS: Balancing Strategies for Improved Outcome,” presented at the EBMT 2025 Annual Meeting in Florence. The session featured expert insights into innovative conditioning strategies aimed at improving outcomes in hematopoietic stem cell transplantation (HSCT).